ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

DCE Advisors Approve New Grant Program On Lung Carcinoma

June 30, 1995

Managed Care: “Natural Alliance” Between Managed Care And Academic Centers, McGivney Says

January 24, 1997

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

In Brief: Beatrice Mintz Appointed to Pontifical Academy; Three Americans Asked to Help Shanghai Group

November 28, 1986

Natural Product Drug Discovery Groups Receive Concept Approval

February 26, 1988

Former NCI Executive Lands Key Senate Staff Position

February 4, 1977